Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alligator Bioscience AB ( (SE:ATORX) ) has shared an announcement.
Alligator Bioscience AB announced that 11 September 2025 is the last day for trading in its warrants series TO 13, with the subscription period for ordinary shares open until 15 September 2025. The exercise of these warrants could significantly increase the company’s share capital and result in a 22% dilution of ordinary shares, potentially raising approximately SEK 30.6 million before issue costs.
More about Alligator Bioscience AB
Alligator Bioscience AB is a biotechnology company focused on developing innovative immuno-oncology therapies. The company specializes in the creation of antibody-based treatments aimed at enhancing the body’s immune response to cancer.
Average Trading Volume: 501,200
Technical Sentiment Signal: Sell
Current Market Cap: SEK132.3M
See more insights into ATORX stock on TipRanks’ Stock Analysis page.